相关实验视频

Updated: May 7, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K

PORT:一种随机的,交叉的,第2阶段研究,对在患有复发性/阻断性多发性骨髓瘤的患者中对外围和中央静脉注射的梅尔夫卢芬进行了随机的,交叉的研究

Ludek Pour1, Ilina Micheva2, Ganna Usenko3

  • 1Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.

Clinical lymphoma, myeloma & leukemia
|March 15, 2024
PubMed
概括

在患有多发性骨髓瘤的患者中,通过外周静脉导管 (PVC) 给药梅尔芬与中央静脉导管 (CVC) 给药具有生物等价性. 这项研究发现,PVC墨芬耐受性良好,提供了潜在的可取替代途径.

关键词:
导管导管是一种导管导管.中心静脉的中心静脉.梅尔法兰是什么意思周围静脉的周边静脉.

更多相关视频

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.9K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

85

相关概念视频

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...